[시장보고서]약국 자동화 시장 : 제품별, 최종 사용자별, 시설별

약국 자동화 시장 : 제품별, 최종 사용자별, 시설별 - 세계 예측(-2030년)

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counter, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient, Retail, ASC), Facility (Large, Mid) - Global Forecast to 2030

상품코드 : 1686701 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 03월

페이지 정보 : 영문 389 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,151,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,607,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,775,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,448,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 약국 자동화 시장은 투약 실수의 발생률 증가와 환자의 안전성 향상에 대한 요구 증가로 2024년에 크게 성장했습니다.

시장 규모는 2024년 66억 5,000만 달러에서 2030년 100억 달러에 이를 것으로 예측되며, 2024-2030년에 CAGR은 7.1%를 나타낼 것으로 전망됩니다. 세계보건기구(WHO)에 따르면, 투약 실수의 약 50%는 처방이나 주문 과정에서 발생하고 있습니다. 또한 간호사와 약사가 투약 실수의 30%-70%를 확인하고 있다는 조사 결과도 있습니다. 병원과 약국에서는 이러한 위험을 줄이고 정확성, 효율성 및 워크플로우 관리를 강화하기 위해 고급 약국 자동화 솔루션을 채택하고 있습니다. 이러한 자동화에 대한 수요 증가는 앞으로 수년간 시장 성장을 가속화할 것으로 예측됩니다.

조사 범위
조사 대상 연도	2022-2030년
기준 연도	2023년
예측 기간	2024-2030년
단위	10억 달러
부문	제품 유형, 구성 요소, 용도, 시설 유형, 최종 사용자
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

유형별로는 로봇/로봇 자동조제 하위 부문이 2023년에 자동조제·보관부문에서 최대의 점유율을 차지했습니다.

이 시스템은 약물을 채우고, 보관하고, 조제할 수 있는 단일/복수의 로봇 암이 있는 로봇을 통합하여 투여 정확도를 높이고 수동으로 실수할 가능성을 줄일 수 있습니다.

"북미가 2023년 약국 자동화 시장을 독점했습니다."

북미는 의료기술의 충분한 채용률, 의료에서의 견고하고 확립된 인프라, 이러한 진보를 지원하는 의료비의 끊임없는 성장 등 여러 요인에 의해 약국 자동화 시장을 독점했습니다. 게다가 만성질환 환자 증가, 개호가 있는 주택과 장기 케어 센터에 대한 수요 증가, 많은 처방수 등이 북미 시장에서의 자동화 수요 증가를 가져오고 있습니다.

BD, OMNICELL, McKesson, Baxter 등의 기업들은 스마트 커넥티드 약국 자동화 솔루션에 투자함으로써 시장을 주도하고 있습니다. 예를 들어 2022년 6월, BD는 Parata Systems 인수에 15억 2,500만 달러를 투자하여 로봇 조제 및 AI 기반 워크플로우 자동화에서 BD의 실적를 확대했습니다. 이 인수는 특히 병원 및 집중처방처리센터에서 약국 자동화의 채용이 가속될 것으로 예측됩니다.

이 보고서는 세계의 약국 자동화 시장에 대한 조사 분석을 통해 주요 촉진요인 및 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.

서론
시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 과제
산업 동향
- 물리적 설치 공간을 최소화한 컴팩트한 소프트웨어 구성
- 처방 조제용 약국 로봇
- 첨단 의약품 추적을 위한 RFID 기술
- 클라우드 기반 약국 자동화 관리 솔루션
- 상호 운용성 강화를 위한 EHR과의 통합
- 의료 자동화에서 빅데이터의 역할
고객의 비즈니스에 영향을 미치는 동향/방해
생태계 분석
밸류체인 분석
기술 분석
- 주요 기술
- 상호보완 기술
- 인접 기술
관세 및 규제 분석
- 관세 데이터(HS CODE 9032)
- 관세 데이터(HS CODE 8422)
- 관세 데이터(HS CODE 8479)
- 규제기관, 정부기관, 기타 조직
- 규제 분석
무역 분석
- 약국 자동화 기기의 무역 분석(HSN CODE 9032)
- 약국 자동화 기기의 무역 분석(HSN CODE 8422)
- 약국 자동화 기기의 무역 분석(HSN CODE 8479)
가격 분석
- 약국 자동화의 참고 가격 : 제품별(2023년)
- 약국 자동화 디바이스의 참고 가격 : 지역별(2023년)
Porter's Five Forces 분석
특허 분석
- 약국 자동화를 위한 특허 출원 동향
- 약국 자동화 관할권 및 상위 신청 국가
- 약국 자동화 시장의 주요 특허
주요 이해관계자와 구매 기준
최종 사용자 분석
- 언멧 요구
- 최종 사용자의 기대
주된 회의와 이벤트(2024-2025년)
사례 연구 분석
투자와 자금조달 시나리오
비즈니스 모델
- 직접 판매 모델(자본 구입 모델)
- 구독 기반 모델(SaaS)
- 사용량 기반 과금 모델(거래 기반 요금제)
- 리스/렌탈 모델
- 매니지드 서비스 모델(아웃소싱·풀 서비스 계약)
- 프리미엄 업그레이드가 포함된 부분 유료화 모델
약국 자동화 시장에 대한 AI/생성형 AI의 영향
- 주요 이용 사례
- AI/생성형 AI 구현 사례 연구
- 상호 연결된 생태계와 인접한 생태계에 대한 AI/인공지능의 영향
- 사용자 준비 상황 및 영향 평가

제6장 약국 자동화 시장 : 제품별

서론
자동 조제 및 보관 시스템
자동 포장 및 라벨링 시스템
자동 테이블형 카운터
자동 약물 조제 시스템
약국 관리 소프트웨어(PMS/PIMS/PIS)
기타 약국 자동화 시스템

제7장 약국 자동화 시장 : 구성 요소별

서론
하드웨어
소프트웨어
서비스

제8장 약국 자동화 시장 : 용도별

서론
집중형 업무
분산형 업무

제9장 약국 자동화 시장 : 시설 유형별

서론
대규모 약국
중소규모 약국

제10장 약국 자동화 시장 : 최종 사용자별

서론
병원 약국
외래수술센터(ASC), 외래케어센터(ACC), 기타 외래 환경
장기 요양 및 생활 보조 시설
소매 약국
약국 혜택 관리 기관 및 통신 판매 약국

제11장 약국 자동화 시장 : 지역별

서론
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽의 거시 경제 전망
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 아시아태평양의 거시 경제 전망
- 일본
- 중국
- 인도
- 기타 아시아태평양
라틴아메리카
- 라틴아메리카의 거시 경제 전망
- 브라질
- 멕시코
- 기타 라틴아메리카
중동 및 아프리카
- 중동 및 아프리카의 거시 경제 전망
- GCC 국가
- 기타 중동 및 아프리카

제12장 경쟁 구도

개요
주요 진입기업의 전략/강점
수익 분석(2019-2023년)
시장 점유율 분석(2023년)
기업 평가 매트릭스 : 주요 기업(2023년)
기업 평가 매트릭스 : 스타트업/중소기업(2023년)
기업 평가 및 재무 지표
브랜드/소프트웨어 비교
경쟁 시나리오

제13장 기업 프로파일

주요 기업
- BD
- OMNICELL
- KUKA AG(SWISSLOG HEALTHCARE)
- BAXTER
- MCKESSON CORPORATION
- ORACLE
- CAPSA HEALTHCARE
- YUYAMA CO., LTD.
- ARXIUM
- SCRIPTPRO, LLC
- RXSAFE, LLC
- PEARSON MEDICAL TECHNOLOGIES, LLC
- DEENOVA SRL
- MEDICAL PACKAGING INC., LLC
- TENSION PACKAGING & AUTOMATION
- NORITSU PHARMACY AUTOMATION
- EUCLID MEDICAL PRODUCTS
- TOUCHPOINT MEDICAL SOLUTIONS
- INNOVATION ASSOCIATES(IA)
- JFCRX
기타 기업
- WILLACH GROUP
- PHARMACY AUTOMATION SYSTEMS, LLC
- ASTERES INC.
- NEWLCON
- ACCU-CHART PLUS HEALTH CARE SYSTEMS, INC.

제14장 부록

KTH

영문 목차

영문목차

The global pharmacy automation market is experiencing significant growth in 2024, driven by the increasing incidence of medication errors and the growing need for enhanced patient safety. The market is projected to reach USD 6.65 billion in 2024 from USD 10.00 billion in 2030, expanding at a CAGR of 7.1% from 2024 to 2030. According to the World Health Organization (WHO), nearly 50% of all medication errors occur during the prescription or ordering process. Additionally, studies indicate that nurses and pharmacists identify between 30% and 70% of medication-ordering errors. Hospitals and pharmacies are increasingly adopting advanced pharmacy automation solutions to mitigate these risks to enhance accuracy, efficiency, and workflow management. This rising demand for automation is expected to accelerate market growth in the coming years.

Scope of the Report
Years Considered for the Study	2022-2030
Base Year	2023
Forecast Period	2024-2030
Units Considered	Value (USD Billion)
Segments	Product Type, Component, Application, Facility Type, and End-User
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Based on type, the robots/robotic automated medication dispensing subsegment accounted for the largest share in automated medication dispensing and storage segment in 2023"

Based on type, the market for automated medication storage and dispensing systems is categorized into robots/robotic automated dispensing systems, carousels, automated dispensing cabinets (ADCs), and others. Robot/robotic automated dispensing systems accounted for the largest share in 2023 of this market. These systems assist in reducing the rate of errors by widening the administration accuracy rate by integrating robots with single/multiple robotic arms that are capable of performing the filling, storing, and dispensing of medications, thereby reducing the chances of manual errors.

"North America dominated the pharmacy automation market in 2023."

The pharmacy automation market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the pharmacy automation market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing cases of the chronic diseases, rising demand for assisted living and long term care centers and high prescription volume resulting in increased demand of automation in North America market.

Companies such as BD, OMNICELL, McKesson, and Baxter are leading the market by investing in smart, connected pharmacy automation solutions. For instance, in June 2022, BD invested USD 1.525 billion in acquisition of Parata Systems, expanding BD's footprint in robotic medication dispensing and AI-based workflow automation. This acquisition is expected to accelerate pharmacy automation adoption, particularly in hospitals and centralized prescription fulfillment centers.

The break-down of primary participants is as mentioned below:

By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
By Designation - Directors: 35%, Managers: 40%, and Others: 25%
By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US) are some of the key players in the pharmacy automation market.

The study includes an in-depth competitive analysis of these key players in the pharmacy automation market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the pharmacy automation market by product type (automated medication dispensing and storage systems, automated packaging and labeling systems, automated tabletop counters, automated medication compounding systems, pharmacy management software (PMS/PIMS/PIS), and other pharmacy automation systems (pharmacy kiosks, pneumatic tubes, tablet splitters, and others), by component (hardware, software, and service), by application (centralized operations and decentralized operations), by facility type (large-scale pharmacies and small and mid-size pharmacies), and by end-user (hospital pharmacies, ambulatory surgery center (ASC), ambulatory care center (ACC), and other outpatient settings, long-term care facilities & assisted living facilities, retail pharmacies, and pharmacy benefit management organization and mail-order pharmacies) and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmacy automation market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the pharmacy automation market. Competitive analysis of upcoming startups in the pharmacy automation market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the pharmacy automation market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (growing need to minimize medication error, decentralization of pharmacies, rising geriatric population leading to increased adoption of automated dispensing systems, growing focus on automation to reduce labor costs, increasing specialty drug dispensing), restraints (high initial capital investments, reluctance to adopt pharmacy automation systems, limited suitability for all medication types, and lack of skilled personnel), opportunities (rising online sales of medicines, expansion of telepharmacy and remote patient management, rising healthcare costs expected to drive the market growth),and challenges (stringent regulatory procedures, risk of cross-contamination, technical failures and system reliability issues, risk of drug name selection errors).
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmacy automation market
Market Development: Comprehensive information about lucrative markets - the report analyses the pharmacy automation market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmacy automation market
Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Oracle (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Mckesson Corporation (US), among others in the pharmacy automation market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Primary sources
  - 2.1.2.2 Key data from primary sources
  - 2.1.2.3 Key industry insights
  - 2.1.2.4 Breakdown of primary interviews
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
- 2.5.1 OVERALL STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PHARMACY AUTOMATION MARKET OVERVIEW
4.2 PHARMACY AUTOMATION MARKET, BY END USER AND COUNTRY
4.3 PHARMACY AUTOMATION MARKET: GEOGRAPHIC SNAPSHOT
4.4 PHARMACY AUTOMATION MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing need to minimize medication errors
  - 5.2.1.2 Decentralization of pharmacies
  - 5.2.1.3 Rising geriatric population and subsequent uptake of automated dispensing systems
  - 5.2.1.4 Growing focus on automation to reduce labor costs
  - 5.2.1.5 Increasing demand for specialty drug dispensing
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High initial capital investments
  - 5.2.2.2 Reluctance to adopt pharmacy automation systems
  - 5.2.2.3 Shortage of skilled personnel
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Gradual shift to online pharmacy services
  - 5.2.3.2 Expansion of telepharmacy & remote patient management services
- 5.2.4 CHALLENGES
  - 5.2.4.1 Stringent regulatory process for automated pharmacy systems
  - 5.2.4.2 Risk of cross-contamination
  - 5.2.4.3 Technical failures and system reliability issues
  - 5.2.4.4 Medication dispensing risks associated with drug name selections
5.3 INDUSTRY TRENDS
- 5.3.1 COMPACT SOFTWARE CONFIGURATIONS WITH MINIMAL PHYSICAL FOOTPRINTS
- 5.3.2 PHARMACY ROBOTICS FOR PRESCRIPTION DISPENSING
- 5.3.3 RFID TECHNOLOGY FOR ADVANCED MEDICATION TRACKING
- 5.3.4 CLOUD-BASED PHARMACY AUTOMATION MANAGEMENT SOLUTIONS
- 5.3.5 INTEGRATION WITH EHR FOR ENHANCED INTEROPERABILITY
- 5.3.6 ROLE OF BIG DATA IN HEALTHCARE AUTOMATION
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
- 5.7.1 KEY TECHNOLOGIES
  - 5.7.1.1 Robotics
  - 5.7.1.2 Robotic Process Automation (RPA)
- 5.7.2 COMPLEMENTARY TECHNOLOGIES
  - 5.7.2.1 E-prescribing systems
  - 5.7.2.2 EHR integration
  - 5.7.2.3 Barcoding & scanning technology
- 5.7.3 ADJACENT TECHNOLOGIES
  - 5.7.3.1 AI & ML
  - 5.7.3.2 Telepharmacy
  - 5.7.3.3 Cold chain management solutions
5.8 TARIFF & REGULATORY ANALYSIS
- 5.8.1 TARIFF DATA (HS CODE 9032)
- 5.8.2 TARIFF DATA (HS CODE 8422)
- 5.8.3 TARIFF DATA (HS CODE 8479)
- 5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.8.5 REGULATORY ANALYSIS
  - 5.8.5.1 North America
  - 5.8.5.2 Europe
  - 5.8.5.3 Asia Pacific
  - 5.8.5.4 Middle East & Africa
  - 5.8.5.5 Latin America
5.9 TRADE ANALYSIS
- 5.9.1 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 9032)
- 5.9.2 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8422)
- 5.9.3 TRADE ANALYSIS FOR PHARMACY AUTOMATION DEVICES (HSN CODE 8479)
5.10 PRICING ANALYSIS
- 5.10.1 INDICATIVE PRICE OF PHARMACY AUTOMATION, BY PRODUCT (2023)
- 5.10.2 INDICATIVE PRICE OF PHARMACY AUTOMATION DEVICES, BY REGION (2023)
5.11 PORTER'S FIVE FORCES ANALYSIS
- 5.11.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.11.2 BARGAINING POWER OF BUYERS
- 5.11.3 THREAT OF SUBSTITUTES
- 5.11.4 THREAT OF NEW ENTRANTS
- 5.11.5 BARGAINING POWER OF SUPPLIERS
5.12 PATENT ANALYSIS
- 5.12.1 PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION
- 5.12.2 JURISDICTION & TOP APPLICANT COUNTRIES FOR PHARMACY AUTOMATION
- 5.12.3 LEADING PATENTS IN PHARMACY AUTOMATION MARKET
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 BUYING CRITERIA
5.14 END-USER ANALYSIS
- 5.14.1 UNMET NEEDS
- 5.14.2 END-USER EXPECTATIONS
5.15 KEY CONFERENCES & EVENTS, 2024-2025
5.16 CASE STUDY ANALYSIS
- 5.16.1 CASE STUDY 1: KING SALMAN MILITARY HOSPITAL IMPLEMENTS PHARMACY AUTOMATION
- 5.16.2 CASE STUDY 2: EVERSPRING PHARMACY AIMED TO IMPROVE EFFICIENCY IN MEDICATION DISPENSING & PACKING WITH LOW COSTS
- 5.16.3 CASE STUDY 3: MCKESSON IMPLEMENTED CLINICAL PROGRAM SOLUTIONS FOR REAL-TIME PATIENT ADHERENCE
5.17 INVESTMENT & FUNDING SCENARIO
5.18 BUSINESS MODELS
- 5.18.1 DIRECT SALES MODEL (CAPITAL PURCHASE MODEL)
- 5.18.2 SUBSCRIPTION-BASED MODEL (SOFTWARE-AS-A-SERVICE: SAAS)
- 5.18.3 PAY-PER-USE MODEL (TRANSACTION-BASED PRICING)
- 5.18.4 LEASE/RENTAL MODEL
- 5.18.5 MANAGED SERVICES MODEL (OUTSOURCING & FULL-SERVICE CONTRACTS)
- 5.18.6 FREEMIUM MODEL WITH PREMIUM UPGRADES
5.19 IMPACT OF AI/GENERATIVE AI ON PHARMACY AUTOMATION MARKET
- 5.19.1 KEY USE CASES
- 5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
  - 5.19.2.1 CASE STUDY 1: GIANT EAGLE LEVERAGES AI-DRIVEN AUTOMATION TO ENHANCE PHARMACY EFFICIENCY & PATIENT SAFETY
- 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  - 5.19.3.1 Medication management market
  - 5.19.3.2 Medical robots market
  - 5.19.3.3 Digital pharmacy market
- 5.19.4 USER READINESS & IMPACT ASSESSMENT
  - 5.19.4.1 User readiness
    - 5.19.4.1.1 User A: Hospital pharmacies
    - 5.19.4.1.2 User B: Retail pharmacies
  - 5.19.4.2 Impact assessment
    - 5.19.4.2.1 User A: Hospital pharmacies
    - 5.19.4.2.2 User B: Retail pharmacies

6 PHARMACY AUTOMATION MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 AUTOMATED MEDICATION DISPENSING & STORAGE SYSTEMS
- 6.2.1 ROBOTIC AUTOMATED DISPENSING SYSTEMS (ROBOTS)
  - 6.2.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market
- 6.2.2 CAROUSELS
  - 6.2.2.1 Improved inventory control & workflow to fuel uptake
- 6.2.3 AUTOMATED DISPENSING CABINETS (ADCS)
  - 6.2.3.1 Provision of secured medication storage & drug tracking benefits to support market growth
6.3 AUTOMATED PACKAGING & LABELING SYSTEMS
- 6.3.1 VIAL PACKAGING
  - 6.3.1.1 Increasing demand for high-quality glass & sustainable vial packaging to drive market
- 6.3.2 POUCH PACKAGING
  - 6.3.2.1 Efficient design for unit/multi-dose medication dispensing to fuel uptake
- 6.3.3 BLISTER PACKAGING
  - 6.3.3.1 Rising emphasis on sustainability & smart packaging to drive market
6.4 AUTOMATED TABLETOP COUNTERS
- 6.4.1 GROWING FOCUS ON INCREASING OPERATING SPEED TO BOOST DEMAND
6.5 AUTOMATED MEDICATION COMPOUNDING SYSTEMS
- 6.5.1 MINIMIZATION OF COMPOUNDING ERRORS AND ELIMINATION OF MEDICATION OUTSOURCING EXPENSES TO FUEL MARKET
6.6 PHARMACY MANAGEMENT SOFTWARE (PMS/PIMS/PIS)
- 6.6.1 INTEGRATION OF AI FOR REGULATORY ADHERENCE TO PROPEL MARKET
6.7 OTHER PHARMACY AUTOMATION SYSTEMS

7 PHARMACY AUTOMATION MARKET, BY COMPONENT

7.1 INTRODUCTION
7.2 HARDWARE
- 7.2.1 ABILITY TO PROVIDE RAPID EFFICIENCY WITH LOW RISK OF MANUAL MEDICATION ERRORS TO DRIVE MARKET
7.3 SOFTWARE
- 7.3.1 ON-PREMISE DEPLOYMENT MODELS
  - 7.3.1.1 Provision of secure, customized, and regulatory-compliant solutions for sensitive patient data to fuel uptake
- 7.3.2 CLOUD-BASED DEPLOYMENT MODELS
  - 7.3.2.1 Growing focus on scalability, AI-integration, and remote accessibility to drive market
7.4 SERVICES
- 7.4.1 OPTIMIZATION OF PHARMACY OPERATIONS THROUGH COMPREHENSIVE AUTOMATION SERVICES TO SUPPORT MARKET GROWTH

8 PHARMACY AUTOMATION MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 CENTRALIZED OPERATIONS
- 8.2.1 HIGHLY BENEFICIAL FOR LARGE HEALTHCARE FACILITIES FOR HIGH-VOLUME MEDICATION PROCESSING TO FUEL MARKET
8.3 DECENTRALIZED OPERATIONS
- 8.3.1 UTILIZATION OF ADCS IN EMERGENCY DEPARTMENTS FOR REAL-TIME MEDICATION ADMINISTRATION TO PROPEL MARKET

9 PHARMACY AUTOMATION MARKET, BY FACILITY TYPE

9.1 INTRODUCTION
9.2 LARGE-SCALE PHARMACIES
- 9.2.1 INTEGRATION OF AI & ML INTO COMPLEX WORKFLOWS TO FUEL UPTAKE
9.3 SMALL & MID-SIZED PHARMACIES
- 9.3.1 GROWING FOCUS ON OFFERING AFFORDABLE AUTOMATED SOLUTIONS TO PROPEL MARKET

10 PHARMACY AUTOMATION MARKET, BY END USER

10.1 INTRODUCTION
10.2 HOSPITAL PHARMACIES
- 10.2.1 INPATIENT PHARMACIES
  - 10.2.1.1 Growing need to minimize waiting times and reduce medication errors to drive market
- 10.2.2 OUTPATIENT PHARMACIES
  - 10.2.2.1 Growing focus on enhancing patient convenience and complying with medication adherence to fuel market
10.3 AMBULATORY SURGERY CENTERS (ASCS), AMBULATORY CARE CENTERS (ACCS), AND OTHER OUTPATIENT SETTINGS
- 10.3.1 INTEGRATION OF ROBOTICS AND AI INTO AUTOMATED SOLUTIONS TO DRIVE MARKET
10.4 LONG-TERM CARE AND ASSISTED LIVING FACILITIES
- 10.4.1 EXPANSION IN GERIATRIC POPULATION TO FUEL MARKET
10.5 RETAIL PHARMACIES
- 10.5.1 GROWING REQUIREMENT FOR AUTOMATED TECHNOLOGY TO ASSIST WITH RAPID MEDICATION DISPENSING TO PROPEL MARKET
10.6 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES
- 10.6.1 RISING FOCUS ON AUTOMATED DISPENSING FACILITIES FOR 90-DAY MEDICATION SUPPLIES TO SUPPORT MARKET GROWTH

11 PHARMACY AUTOMATION MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 Technological shift towards advanced pharmacy solutions to drive market
- 11.2.3 CANADA
  - 11.2.3.1 Increasing uptake of AI & ML to fuel market
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 UK
  - 11.3.2.1 Growing cases of medication errors to fuel uptake
- 11.3.3 GERMANY
  - 11.3.3.1 Hub for advanced automation technologies to propel market
- 11.3.4 FRANCE
  - 11.3.4.1 Favorable government initiatives for healthcare digitization to drive market
- 11.3.5 ITALY
  - 11.3.5.1 Rising focus on enhancing healthcare efficiency to support market growth
- 11.3.6 SPAIN
  - 11.3.6.1 Rising uptake of ADCs for high prescription volumes to fuel uptake
- 11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 JAPAN
  - 11.4.2.1 Incorporation of robotic dispensing systems in pharmacies to fuel market
- 11.4.3 CHINA
  - 11.4.3.1 Rising need for medication safety to support market growth
- 11.4.4 INDIA
  - 11.4.4.1 Favorable digital health initiatives to propel market
- 11.4.5 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
  - 11.5.2.1 High incidence of prescription errors to drive market
- 11.5.3 MEXICO
  - 11.5.3.1 Growing focus on medication safety to fuel uptake
- 11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
- 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 11.6.2 GCC COUNTRIES
  - 11.6.2.1 Rising adoption of automation solutions to drive market
- 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACY AUTOMATION MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Region footprint
  - 12.5.5.3 Product footprint
  - 12.5.5.4 Component footprint
  - 12.5.5.5 Application footprint
  - 12.5.5.6 Facility type footprint
  - 12.5.5.7 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 12.6.5.1 Detailed list of key startups/SMEs
  - 12.6.5.2 Competitive benchmarking of key emerging players/startups
12.7 COMPANY VALUATION & FINANCIAL METRICS
- 12.7.1 FINANCIAL METRICS
- 12.7.2 COMPANY VALUATION
12.8 BRAND/SOFTWARE COMPARISON
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT/SERVICE LAUNCHES
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS
- 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 BD
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products/Services offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Deals
    - 13.1.1.3.2 Other developments
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Key strengths
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses & competitive threats
- 13.1.2 OMNICELL
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products/Services offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Product/Service launches
    - 13.1.2.3.2 Deals
    - 13.1.2.3.3 Expansions
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Key strengths
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses & competitive threats
- 13.1.3 KUKA AG (SWISSLOG HEALTHCARE)
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products/Services offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Product/Service launches
    - 13.1.3.3.2 Deals
    - 13.1.3.3.3 Other developments
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Key strengths
    - 13.1.3.4.2 Strategic choices
    - 13.1.3.4.3 Weaknesses & competitive threats
- 13.1.4 BAXTER
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products/Services offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Products/Service launches
    - 13.1.4.3.2 Other developments
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Key strengths
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses & competitive threats
- 13.1.5 MCKESSON CORPORATION
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products/Services offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Product/Service launches
    - 13.1.5.3.2 Other developments
- 13.1.6 ORACLE
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products/Services offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Product/Service launches & enhancements
    - 13.1.6.3.2 Deals
  - 13.1.6.4 MnM view
    - 13.1.6.4.1 Key strengths
    - 13.1.6.4.2 Strategic choices
    - 13.1.6.4.3 Weaknesses & competitive threats
- 13.1.7 CAPSA HEALTHCARE
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products/Services offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Product/Service launches & enhancements
    - 13.1.7.3.2 Deals
    - 13.1.7.3.3 Expansions
    - 13.1.7.3.4 Other developments
- 13.1.8 YUYAMA CO., LTD.
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products/Services offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Product/Service launches
- 13.1.9 ARXIUM
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products/Services offered
- 13.1.10 SCRIPTPRO, LLC
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products/Services offered
- 13.1.11 RXSAFE, LLC
  - 13.1.11.1 Business overview
  - 13.1.11.2 Products/Services offered
  - 13.1.11.3 Recent developments
    - 13.1.11.3.1 Deals
- 13.1.12 PEARSON MEDICAL TECHNOLOGIES, LLC
  - 13.1.12.1 Business overview
  - 13.1.12.2 Products/Services offered
  - 13.1.12.3 Recent development
    - 13.1.12.3.1 Products/Service launches
    - 13.1.12.3.2 Other developments
- 13.1.13 DEENOVA S.R.L.
  - 13.1.13.1 Business overview
  - 13.1.13.2 Products/Services offered
  - 13.1.13.3 Recent developments
    - 13.1.13.3.1 Product/Service launches
    - 13.1.13.3.2 Deals
    - 13.1.13.3.3 Expansions
    - 13.1.13.3.4 Other developments
- 13.1.14 MEDICAL PACKAGING INC., LLC
  - 13.1.14.1 Business overview
  - 13.1.14.2 Products/Services offered
  - 13.1.14.3 Recent developments
    - 13.1.14.3.1 Product/Service launches
- 13.1.15 TENSION PACKAGING & AUTOMATION
  - 13.1.15.1 Business overview
  - 13.1.15.2 Products/Services offered
  - 13.1.15.3 Recent developments
    - 13.1.15.3.1 Product/Service launches
    - 13.1.15.3.2 Deals
    - 13.1.15.3.3 Other developments
- 13.1.16 NORITSU PHARMACY AUTOMATION
  - 13.1.16.1 Business overview
  - 13.1.16.2 Products/Services offered
    - 13.1.16.2.1 Product/Service launches
- 13.1.17 EUCLID MEDICAL PRODUCTS
  - 13.1.17.1 Business overview
  - 13.1.17.2 Products/Services offered
  - 13.1.17.3 Recent developments
    - 13.1.17.3.1 Deals
- 13.1.18 TOUCHPOINT MEDICAL SOLUTIONS
  - 13.1.18.1 Business overview
  - 13.1.18.2 Products/Services offered
  - 13.1.18.3 Recent developments
    - 13.1.18.3.1 Product/Service launches
    - 13.1.18.3.2 Deals
- 13.1.19 INNOVATION ASSOCIATES (IA)
  - 13.1.19.1 Business overview
  - 13.1.19.2 Products/Services offered
  - 13.1.19.3 Recent developments
    - 13.1.19.3.1 Product/Service launches
    - 13.1.19.3.2 Deals
    - 13.1.19.3.3 Expansions
    - 13.1.19.3.4 Other developments
- 13.1.20 JFCRX
  - 13.1.20.1 Business overview
  - 13.1.20.2 Products/Services offered
  - 13.1.20.3 Recent developments
    - 13.1.20.3.1 Product/Service launches
    - 13.1.20.3.2 Deals
    - 13.1.20.3.3 Expansions
13.2 OTHER PLAYERS
- 13.2.1 WILLACH GROUP
- 13.2.2 PHARMACY AUTOMATION SYSTEMS, LLC
- 13.2.3 ASTERES INC.
- 13.2.4 NEWLCON
- 13.2.5 ACCU-CHART PLUS HEALTH CARE SYSTEMS, INC.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS